» Articles » PMID: 36081527

SOCS3 Attenuates Dexamethasone-Induced M2 Polarization by Down-Regulation of GILZ Via ROS- and P38 MAPK-Dependent Pathways

Overview
Journal Immune Netw
Date 2022 Sep 9
PMID 36081527
Authors
Affiliations
Soon will be listed here.
Abstract

Suppressors of cytokine signaling (SOCS) have emerged as potential regulators of macrophage function. We have investigated mechanisms of SOCS3 action on type 2 macrophage (M2) differentiation induced by glucocorticoid using human monocytic cell lines and mouse bone marrow-derived macrophages. Treatment of THP1 monocytic cells with dexamethasone (Dex) induced ROS generation and M2 polarization promoting IL-10 and TGF-β production, while suppressing IL-1β, TNF-α and IL-6 production. SOCS3 over-expression reduced, whereas SOCS3 ablation enhanced IL-10 and TGF-β induction with concomitant regulation of ROS. As a mediator of M2 differentiation, glucocorticoid-induced leucine zipper (GILZ) was down-regulated by SOCS3 and up-regulated by shSOCS3. The induction of GILZ and IL-10 by Dex was dependent on ROS and p38 MAPK activity. Importantly, GILZ ablation led to the inhibition of ROS generation and anti-inflammatory cytokine induction by Dex. Moreover, GILZ knock-down negated the up-regulation of IL-10 production induced by shSOCS3 transduction. Our data suggest that SOCS3 targets ROS- and p38-dependent GILZ expression to suppress Dex-induced M2 polarization.

Citing Articles

3D Stem Cell Spheroids with 2D Hetero-Nanostructures for In Vivo Osteogenic and Immunologic Modulated Bone Repair.

Liu X, Astudillo Potes M, Dashtdar B, Schreiber A, Tilton M, Li L Adv Healthc Mater. 2024; 13(12):e2303772.

PMID: 38271276 PMC: 11404522. DOI: 10.1002/adhm.202303772.


CD163 protein inhibits lipopolysaccharide-induced macrophage transformation from M2 to M1 involved in disruption of the TWEAK-Fn14 interaction.

Chen L, Mei W, Song J, Chen K, Ni W, Wang L Heliyon. 2023; 10(1):e23223.

PMID: 38148798 PMC: 10750081. DOI: 10.1016/j.heliyon.2023.e23223.


Macrophage polarization in spinal cord injury repair and the possible role of microRNAs: A review.

Wang J, Tian F, Cao L, Du R, Tong J, Ding X Heliyon. 2023; 9(12):e22914.

PMID: 38125535 PMC: 10731087. DOI: 10.1016/j.heliyon.2023.e22914.


Macrophage Polarization and the Regulation of Bone Immunity in Bone Homeostasis.

Hu K, Shang Z, Yang X, Zhang Y, Cao L J Inflamm Res. 2023; 16:3563-3580.

PMID: 37636272 PMC: 10460180. DOI: 10.2147/JIR.S423819.


[The regulatory role and related mechanisms of macrophages in wound healing].

He W, Yan L Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023; 39(2):106-113.

PMID: 36878519 PMC: 11630181. DOI: 10.3760/cma.j.cn501225-20230110-00010.


References
1.
Whyte C, Bishop E, Ruckerl D, Gaspar-Pereira S, Barker R, Allen J . Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function. J Leukoc Biol. 2011; 90(5):845-54. DOI: 10.1189/jlb.1110644. View

2.
Tamiya T, Kashiwagi I, Takahashi R, Yasukawa H, Yoshimura A . Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol. 2011; 31(5):980-5. DOI: 10.1161/ATVBAHA.110.207464. View

3.
Oh J, Hur M, Lee C . SOCS1 protects protein tyrosine phosphatases by thioredoxin upregulation and attenuates Jaks to suppress ROS-mediated apoptosis. Oncogene. 2009; 28(35):3145-56. DOI: 10.1038/onc.2009.169. View

4.
Zhang X, Goncalves R, Mosser D . The isolation and characterization of murine macrophages. Curr Protoc Immunol. 2008; Chapter 14:14.1.1-14.1.14. PMC: 2834554. DOI: 10.1002/0471142735.im1401s83. View

5.
Berrebi D, Bruscoli S, Cohen N, Foussat A, Migliorati G, Bouchet-Delbos L . Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood. 2002; 101(2):729-38. DOI: 10.1182/blood-2002-02-0538. View